Real-World Data / Real-Word Evidence Resources

1. 5 Key Takeaways From The FDA's Real-World Evidence Guidance 8/19/2024

   With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.

2. RWD/RWE In 2023: Regulatory Policy World Tour 7/5/2023

   Learn about what the industry considers RWD/RWE priorities for the year, as well as current efforts being taken within each region around the globe.

3. Reframing Vendor Selection: Beyond Price And Past Relationships 10/21/2025

   An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.

4. How To Reduce Risk And Effort When Migrating A TMF 10/19/2023

   Utilize this summary of key tips, checklists, and lessons learned to mitigate the risks and efforts associated with migrating a trial master file.

5. Why Research Sites Don't Use EMR As The Source Data Collection Tool 9/21/2022

   Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.

6. Modern Data Platform Strategies That Accelerate Clinical Development 11/26/2025

   A modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.

7. Leveraging The Window Of Opportunity In Clinical Trial Recruitment 5/13/2023

   Access to real-world data now makes it possible to identify potential trial participants, wherever they are.

8. RWD For Early Clinical Development Planning And Strategy 9/19/2023

   Delve into this use case where Citeline’s Real-World Data was used to inform clinical development strategy and differentiate target product profiles through patient journey mapping.

9. Why Use Scorecards To Make Vendor Selection Decisions 10/21/2025

   Scorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.

10. 6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies 2/3/2025

    Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.